Nature Communications · 2023 · 45 citations · 49 references
Life SciencesBiochemistryPharmacologyDrug MetabolismEnzymologyMetabolismCholesterol BiosynthesisCholesterol MetabolismCytochrome P450 EnzymesCytochrome P450-mediated MetabolismSteroid BiosynthesisSteroidogenic EnzymesCholesterol Side-chain Cleavage EnzymeCytochrome P450 IsoenzymesCytochrome P450 Metabolic PathwaysCytochrome P450 PathwaysCytochrome P450 Side-chain Cleavage EnzymeProtein Structural AnalysisRate-limiting EnzymesSteroid Side-chain Cleavage
Abstract Digoxin extracted from the foxglove plant is a widely prescribed natural product for treating heart failure. It is listed as an essential medicine by the World Health Organization. However, how the foxglove plant synthesizes digoxin is mostly unknown, especially the cytochrome P450 sterol side chain cleaving enzyme (P450 scc ), which catalyzes the first and rate-limiting step. Here we identify the long-speculated foxglove P450 scc through differential transcriptomic analysis. This enzyme converts cholesterol and campesterol to pregnenolone, suggesting that digoxin biosynthesis starts from both sterols, unlike previously reported. Phylogenetic analysis indicates that this enzyme arises from a duplicated cytochrome P450 CYP87A gene and is distinct from the well-characterized mammalian P450 scc . Protein structural analysis reveals two amino acids in the active site critical for the foxglove P450 scc ’s sterol cleavage ability. Identifying the foxglove P450 scc is a crucial step toward completely elucidating digoxin biosynthesis and expanding the therapeutic applications of digoxin analogs in future work.
49
Highly accurate protein structure prediction with AlphaFold
John Jumper, Alexander Pritzel, Tim Green et al. · Nature · 2021 · 45.2K citations · Full text
Gene Ontology: tool for the unification of biology
Michael Ashburner, Catherine A. Ball, Judith A. Blake et al. · Nature Genetics · 2000 · 44.6K citations · Full text